SitesBLAST
Comparing WP_004687208.1 NCBI__GCF_000022745.1:WP_004687208.1 to proteins with known functional sites using BLASTp with E ≤ 0.001.
Or try Sites on a Tree, PaperBLAST, Conserved Domains, or compare to all protein structures
Found 13 hits to proteins with known functional sites (download)
8jttA Hoct1 in complex with metformin in outward occluded conformation (see paper)
27% identity, 73% coverage: 79:389/426 of query aligns to 89:405/454 of 8jttA
Sites not aligning to the query:
8jtzA Hoct1 in complex with spironolactone in outward facing partially occluded conformation (see paper)
27% identity, 73% coverage: 79:389/426 of query aligns to 165:481/530 of 8jtzA
O15245 Solute carrier family 22 member 1; Organic cation transporter 1; hOCT1 from Homo sapiens (Human) (see 10 papers)
27% identity, 73% coverage: 79:389/426 of query aligns to 167:483/554 of O15245
- S189 (= S101) to L: no changes in MPP(+) uptake; dbSNP:rs34104736
- G220 (≠ A140) to V: affects transporter activity; reduction of MPP(+) uptake when associated with V-408; dbSNP:rs36103319
- Y240 (≠ P160) mutation to F: Decreased TEA uptake.
- P283 (= P195) to L: in dbSNP:rs4646277; mutation to A: Decreased TEA uptake.
- R287 (vs. gap) to G: in dbSNP:rs4646278
- P341 (≠ H240) to L: affects transporter activity; reduction of TEA uptake; reduction o MPP(+) uptake when associated with V-408; largely localized to the plasma membrane; dbSNP:rs2282143
- R342 (≠ K241) to H: no changes in MPP(+) uptake when associated with V-408; dbSNP:rs34205214
- Y361 (= Y275) mutation to F: Decreased TEA uptake.
- Y376 (≠ F290) mutation to F: Decreased TEA uptake.
- G401 (= G306) to S: affects transporter activity; reduction of MPP(+), serotonin and TEA uptake; no MPP(+) uptake when associated with L-160; dbSNP:rs34130495
- M408 (≠ I313) to V: does not affect transporter activity; no changes in MPP(+) uptake when associated with F-14; no changes in MPP(+) uptake when associated with F-85; no changes in MPP(+) uptake when associated with L-189; no changes in MPP(+) uptake when associated with H-342; no changes in MPP(+) uptake when associated with M-420 del; no changes in MPP(+) uptake when associated with I-440; no changes in MPP(+) uptake when associated with I-461; no changes in MPP(+) uptake when associated with M-488; reduction of MPP uptake when associated with C-61; no MPP(+) uptake when associated with V-220; reduction of MPP(+) uptake when associated with L-341; no MPP(+) uptake when associated with S-401; no MPP(+) uptake when associated with R-465; dbSNP:rs628031
- M420 (= M325) natural variant: Missing (reduction of serum O-isobutanoyl-(R)-carnitine levels; no change in MPP(+) uptake; no changes in MPP(+) uptake when associated with V-408; dbSNP:rs72552763)
- M440 (= M347) to I: in dbSNP:rs35956182
- V461 (= V366) to I: no changes in MPP(+) uptake when associated with V-408; dbSNP:rs34295611
- G465 (= G370) to R: reduction of the localization to the basolateral membrane; no MPP(+) uptake when associated with V-408; dbSNP:rs34059508; mutation to A: No changes in MPP(+) uptake.
Sites not aligning to the query:
- 14 S → F: exclusively found in the African American population; increased MPP(+) uptake when associated with V-408; dbSNP:rs34447885
- 24 I→L: No change in fenoterol uptake. No change in trospium uptake. No change in terbutaline uptake.
- 28 L→I: No change in fenoterol uptake. No change in trospium uptake. No change in terbutaline uptake.
- 31 A→S: No change in fenoterol uptake. No change in trospium uptake. No change in terbutaline uptake.
- 32 F→L: No change in fenoterol uptake. Decreased trospium uptake. Decreased trospium affinity.
- 36 C→Y: Increased fenoterol uptake. Increased fenoterol affinity. No change in trospium uptake. No change in terbutaline uptake. No change in terbutaline affinity.
- 41 F → L: in dbSNP:rs2297373
- 61 R → C: affects transporter activity; reduction of MPP(+) uptake; reduction of serum O-isobutanoyl-(R)-carnitine levels; reduction of MPP(+) uptake when associated with V-408; dbSNP:rs12208357
- 85 L → F: no changes in MPP(+) uptake; when associated with V-408; dbSNP:rs35546288
- 88 C → R: affects transporter activity; reduction of MPP(+), serotonin and TEA uptake; dbSNP:rs55918055
- 160 L → F: no changes in both MPP(+) and TEA uptake; abolishes MPP(+) uptake when associated with S-401; largely localized to the plasma membrane; dbSNP:rs683369
- 488 R → M: no changes in MPP(+) uptake when associated with V-408; dbSNP:rs35270274
8sc2A Human oct1 bound to diltiazem in inward-open conformation (see paper)
26% identity, 73% coverage: 79:389/426 of query aligns to 149:422/453 of 8sc2A
Sites not aligning to the query:
Q9VCA2 Organic cation transporter protein from Drosophila melanogaster (Fruit fly) (see paper)
26% identity, 75% coverage: 73:390/426 of query aligns to 143:475/548 of Q9VCA2
Sites not aligning to the query:
- 97 modified: carbohydrate, N-linked (GlcNAc...) asparagine
Q8NLB7 Gentisate transporter from Corynebacterium glutamicum (strain ATCC 13032 / DSM 20300 / JCM 1318 / BCRC 11384 / CCUG 27702 / LMG 3730 / NBRC 12168 / NCIMB 10025 / NRRL B-2784 / 534) (see paper)
26% identity, 49% coverage: 16:222/426 of query aligns to 39:228/444 of Q8NLB7
- D54 (= D31) mutation to A: Loss of transport activity.; mutation to E: Retains 50% of its transport activity.
- D57 (vs. gap) mutation to A: Loss of transport activity.; mutation to E: Retains 50% of its transport activity.
- R103 (≠ K84) mutation to A: Loss of transport activity.
Sites not aligning to the query:
- 309 W→V: Loss of transport activity.
- 312 D→A: Loss of transport activity.
- 313 R→A: Loss of transport activity.
- 317 mutation I->H,Y: Loss of transport activity.
- 386 R→A: Loss of transport activity.
8sc6A Human oct1 bound to thiamine in inward-open conformation (see paper)
26% identity, 73% coverage: 79:389/426 of query aligns to 149:415/447 of 8sc6A
8et8A Cryo-em structure of the organic cation transporter 1 in complex with verapamil (see paper)
24% identity, 73% coverage: 79:389/426 of query aligns to 166:482/532 of 8et8A
- binding (2S)-2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile: K213 (≠ G134), W216 (= W137), Q240 (= Q161), W353 (= W268), Y360 (= Y275), F378 (≠ I289), S381 (≠ G292), E385 (≠ P296), C449 (≠ G355), S469 (≠ F375)
Sites not aligning to the query:
8et7A Cryo-em structure of the organic cation transporter 1 in complex with diphenhydramine (see paper)
24% identity, 73% coverage: 79:389/426 of query aligns to 166:482/532 of 8et7A
Sites not aligning to the query:
8sc3A Human oct1 bound to fenoterol in inward-open conformation (see paper)
26% identity, 73% coverage: 79:389/426 of query aligns to 149:413/445 of 8sc3A
O15244 Solute carrier family 22 member 2; Organic cation transporter 2; hOCT2 from Homo sapiens (Human) (see 8 papers)
25% identity, 79% coverage: 54:389/426 of query aligns to 145:484/555 of O15244
- M165 (≠ A76) to I: lower Vmax for MPP(+) transport; no change in transport efficiency (Vmax/Km) and clearance of cyclo(his-pro) and salsolinol; dbSNP:rs8177507
- Y169 (≠ H80) mutation to F: No change in TEA uptake.
- T201 (≠ A112) to M: in dbSNP:rs145450955
- Y241 (≠ P160) mutation to F: Slight decrease in TEA uptake. No change in tyrosine phosphorylation. Strong decrease in TEA uptake; when associated with F-362. Strong decrease in TEA and metformin uptake and YES1-mediated tyrosine phosphorylation; when associated with F-362 and F-377.
- Y257 (vs. gap) mutation to F: No change in TEA uptake.
- S270 (≠ T183) to A: decreased Ki value for TBA inhibition of MPP(+); no change in transport efficiency (Vmax/Km) and clearance of cyclo(his-pro) and salsolinol; dbSNP:rs316019
- Y279 (= Y190) mutation to F: No change in TEA uptake.
- Y280 (≠ G191) mutation to F: No change in TEA uptake.
- P284 (= P195) mutation to A: Decreased TEA and metformin uptake. Decreased tyrosine phosphorylation.
- PESPR 284:288 (≠ PFIAS 195:199) Proline-rich sequence
- S286 (≠ I197) mutation to A: No change in TEA and metformin uptake. No change in tyrosine phosphorylation.
- P287 (≠ A198) mutation to A: Decreased TEA and metformin uptake. Decreased tyrosine phosphorylation.
- Y362 (= Y275) mutation to F: Decreased TEA uptake and YES1-mediated tyrosine phosphorylation. Strong decrease in TEA uptake; when associated with F-241. Strong decrease in TEA uptake; when associated with F-377. Strong decrease in TEA and metformin uptake and YES1-mediated tyrosine phosphorylation; when associated with F-241 and F-377.
- Y377 (≠ G287) mutation to F: Slight decrease in TEA uptake. No change in tyrosine phosphorylation. Strong decrease in TEA uptake; when associated with F-362. Strong decrease in TEA and metformin uptake and YES1-mediated tyrosine phosphorylation; when associated with F-241 and F-362.
- R400 (= R304) to C: lower Vmax and reduced Ki value for TBA inhibition of MPP(+); lower transport efficiency (Vmax/Km) and clearance of cyclo(his-pro); no change in transport efficiency (Vmax/Km) and clearance of salsolinol; dbSNP:rs8177516
- K432 (≠ G338) to Q: lower Km value for MPP(+) and reduced Ki value for TBA inhibition of MPP; no change in transport efficiency (Vmax/Km) and clearance of cyclo(his-pro) and salsolinol; dbSNP:rs8177517
- Y458 (≠ F362) mutation to F: No change in TEA uptake.
Sites not aligning to the query:
- 54 P → S: in dbSNP:rs8177504
- 73 Y→F: No change in TEA uptake.
- 92 Y→F: No change in TEA uptake.
- 128 Y→F: No change in TEA uptake.
- 544 Y→F: No change in TEA uptake.
8ju0A Hoct1 in complex with spironolactone in inward facing occluded conformation (see paper)
26% identity, 73% coverage: 79:389/426 of query aligns to 145:401/431 of 8ju0A
Sites not aligning to the query:
P36035 Carboxylic acid transporter protein homolog from Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast) (see paper)
29% identity, 40% coverage: 66:234/426 of query aligns to 183:336/616 of P36035
Sites not aligning to the query:
- 1 modified: Initiator methionine, Removed
- 9 modified: Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)
- 338 modified: Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)
Query Sequence
>WP_004687208.1 NCBI__GCF_000022745.1:WP_004687208.1
MTVAEAVAPQANSVRRVLTASMIGTTIEFFDFYIYATAAVIVFPHLFFPASDGNSALLQS
FATFAIAFFARPVGAAIFGHFGDKIGRKATLVAALMTMGLSTVAIGFLPTYASIGVAAPL
LLALCRLGQGLGLGGEWGGAVLLATENAPEGKRTWYGMFPQLGAPAGFILATGIFLLLAE
TMTEEQFFAYGWRVPFIASAILVAVGLFIRLRIAETPEFQKAIDKAERVAVPAAQLFRHH
KMNLFLGTIGTMATFVLFYLMTVFSLGWGTRALGYSREEFLVLQMIGVIFFGLTIPLSAL
LSDRYGMRTIMVIVTVLIGLYGFIMAPLFAAGTAGVLGFLIIGFGLMGMTYGPIGAVLAE
PFPTSVRYTGASLAFNLAGILGASLAPYIATWLATDYGFAYVGYYMVAAAIISLIGFVFI
TLKDKK
Or try a new SitesBLAST search
SitesBLAST's Database
SitesBLAST's database includes
(1) SwissProt
entries with experimentally-supported functional features;
and (2) protein structures with bound ligands, from the
BioLip database.
by Morgan Price,
Arkin group
Lawrence Berkeley National Laboratory